1-6 of 6
Caroline A. Lindemans
Close
Sort by
Journal Articles

Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia

Linde Dekker, Friso G. Calkoen, Yilin Jiang, Hilly Blok, Saskia R. Veldkamp, Coco De Koning, Maike Spoon, Rick Admiraal, Peter Hoogerbrugge, Britta Vormoor, H. Josef Vormoor, Henk Visscher, Marc Bierings, Marieke Van Der Vlugt, Harm Van Tinteren, A. Laura Nijstad, Alwin D. R. Huitema, Kim C. M. Van Der Elst, Rob Pieters, Caroline A. Lindemans, Stefan Nierkens
Journal: Blood Advances
Blood Adv (2022) 6 (7): 1969–1976.
https://doi.org/10.1182/bloodadvances.2021006700
Published: 2022
Includes: Supplemental data
Journal Articles

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen

Clinical Trials & Observations
A. Birgitta Versluijs, Coco C. H. de Koning, Arjan C. Lankester, Stefan Nierkens, Wouter J. Kollen, Dorine Bresters, Caroline A. Lindemans, Jaap Jan Boelens, Marc Bierings
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1719–1730.
https://doi.org/10.1182/bloodadvances.2021005224
Published: 2022
Includes: Supplemental data
Journal Articles

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy

Clinical Trials & Observations
Robert Chiesa, Jaap Jan Boelens, Christine N. Duncan, Jörn-Sven Kühl, Caroline Sevin, Neena Kapoor, Vinod K. Prasad, Caroline A. Lindemans, Simon A. Jones, Hernan M. Amartino, Mattia Algeri, Nancy Bunin, Cristina Diaz-de-Heredia, Daniel J. Loes, Esther Shamir, Alison Timm, Elizabeth McNeil, Andrew C. Dietz, Paul J. Orchard
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1512–1524.
https://doi.org/10.1182/bloodadvances.2021005294
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses

Brigitte T.A. van den Broek, Caroline A. Lindemans, Jaap Jan Boelens, Eveline M. Delemarre, Julia Drylewicz, Nanda Verhoeven-Duif, Peter M. van Hasselt, Stefan Nierkens
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3092–3101.
https://doi.org/10.1182/bloodadvances.2020003824
Published: 2021
Includes: Supplemental data
Journal Articles

Hurdles in treating Hurler disease: potential routes to achieve a “real” cure

Brigitte T. A. van den Broek, Jaap van Doorn, Charlotte V. Hegeman, Stefan Nierkens, Caroline A. Lindemans, Nanda Verhoeven-Duif, Jaap Jan Boelens, Peter M. van Hasselt
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2837–2849.
https://doi.org/10.1182/bloodadvances.2020001708
Published: 2020
Journal Articles

Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1

Clinical Trials & Observations
Celalettin Ustun, Soyoung Kim, Min Chen, Amer M. Beitinjaneh, Valerie I. Brown, Parastoo B. Dahi, Andrew Daly, Miguel Angel Diaz, Cesar O. Freytes, Siddhartha Ganguly, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Taiga Nishihori, Richard F. Olsson, Kristin M. Page, Genovefa Papanicolaou, Ayman Saad, Sachiko Seo, Basem M. William, John R. Wingard, Baldeep Wirk, Jean A. Yared, Miguel-Angel Perales, Jeffery J. Auletta, Krishna V. Komanduri, Caroline A. Lindemans, Marcie L. Riches
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2525–2536.
https://doi.org/10.1182/bloodadvances.2019000226
Published: 2019